Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Spinal Cord Neoplasms 1Optic Nerve Glioma 1Oligodendroglioma 1Meningioma 1Medulloblastoma 1Familial ependymoma 1Central Nervous System Neoplasms 1Breast Neoplasms 1Astrocytoma 1

Interventions

Temozolomide 7Carboplatin 4Vincristine 3Surveys and Questionnaires 3Radiotherapy 3Magnetic Resonance Imaging 3Bevacizumab 3Vorinostat 2Magnetic Resonance Spectroscopy 2Immunoglobulin G 2Fluorodeoxyglucose F18 2Etoposide 2Disulfides 2veliparib 1tozuleristide 1romidepsin 1lonafarnib 1ispinesib 1etoposide phosphate 1emvododstat 1cediranib 1Valproic Acid 1Thiotepa 1Standard of Care 1Saline Solution 1Radiosurgery 1Radiation 1Pregabalin 1Peripheral Blood Stem Cell Transplantation 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Spinal Cord Neoplasms × emvododstat × Clear all
NCT01158300 2015-05-04

PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors

Pediatric Brain Tumor Consortium

Phase 1 Completed
28 enrolled
CNS

Familial ependymoma, Astrocytoma, Medulloblastoma, Meningioma, Oligodendroglioma, Spinal Cord Neoplasms, Central Nervous System Neoplasms, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡